000			04801cam a2200409Ii 4500
001			96106
003			ES-MaUEC
005			20230102112738.0
006			m o d
007			cr |n|||||||||
008			170602s2017 si a ob 001 0 eng d
020			_a9789811035364 _q(electronic bk.)
020			_a9811035369 _q(electronic bk.)
020			_z9789811035357
020			_z9811035350
040			_aYDX _cYDX _dN$T _dEBLCP _dN$T _dGW5XE _dUAB _dESU _dAZU _dUPM _dOCLCF _dIOG _dCOO _dYDX _dOCLCO _dMERER _dOCLCQ _dOCLCO _dOCLCA _dU3W _dES-MaUEC _bspa
050		4	_aRC280.B48 _b2017 EB
245	0	0	_aSurgical pathology of hepatobiliary tumors _cWen-Ming Cong, editor.
264		1	_aSingapore _bSpringer International Publishing _c2017
300			_a1 recurso en línea _bilustraciones
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
504			_aIncluye referencias bibliográficas e índice
505	0		_aForeword; Preface; Contents; Editors and Contributors; Academic Consultant; Editor; Special Guest Authors; Contributors; Academic Secretary; 1: My View on the Biological Features and Surgical Treatment of Liver Cancer; 1.1 Surgical Treatment in the Pathological Context; 1.2 Biological Hallmarks of Cancer; 1.3 Outlook for Surgical Treatment in the Context of Pathology-Biology; 1.3.1 Early Diagnosis and Treatment Is Still Important but Limited; 1.3.2 The Combined Treatment Model Will Be Changed.
505	8		_a1.3.3 The Residual Cancer Metastasis-ƯPromoting Effect of Tumor Elimination Therapy Will Be Brought to Attention1.3.4 Cancer Metastasis and Recurrence Will Focus on Systemic Intervention; 1.3.5 Personalized Treatment Will Be Divided into Holistic and Molecular Levels; 1.3.6 The Biological Hallmarks of Liver Cancer Will Be the Key to Success of Surgical Treatment; References; 2: Thinking on Innovative Research of Liver Cancer and Clinical Transformation; 2.1 Early Warning and Early Diagnosis Are the Breakthrough Points for Innovative Research on Liver Cancer.
505	8		_a2.2 Research on Molecular Regulation Network Will Provide New Drug Target for Biotherapy of Liver Cancer2.3 Metabolic Abnormality Is Closely Linked with the Genesis and Progression of Liver Cancer; 2.4 Liver Cancer Stem Cells Promote the Genesis and Progression and Recurrence and Metastasis of Liver Cancer; 2.5 Molecular Typing and Personalized Therapy Are the Only Ways to Cure Liver Cancer; 2.6 Prospect; References; 3: Researches on Surgical Pathology of Hepatobiliary Tumors in EHBH; 3.1 American Hepatopathologist Professor Hugh A. Edmondson.
505	8		_a3.2 British Hepatopathologist Professor Anthony PP3.3 American Hepatopathologist Professor Anthony J. Demetris; 3.4 American Hepatopathologist Professor Kamal G. Ishak; 3.5 American Hepatopathologist Professor Swan Nio Thung; 3.6 Conclusions; References; 4: Clonal Origins of Postoperative Recurrent Hepatocellular Carcinoma; 4.1 Occurrence of Recurrent Hepatocellular Carcinoma; 4.2 Clonal Origin of Recurrent Hepatocellular Carcinoma; 4.2.1 Monoclonal and Polyclonal Origin; 4.2.1.1 IM-RHCC; 4.2.1.2 MO-RHCC; 4.2.2 Multifocal Growth and Multicentric Origin.
505	8		_a4.3 Clinical Features of Recurrent Hepatocellular Carcinoma4.3.1 Pathological Diagnostic Criteria; 4.3.2 Clinical Diagnostic Criteria; 4.4 Molecular Pathodiagnosis of HCC Clonal Origin; 4.5 Prospection; References; 5: Tumor-Like Lesions of the Liver and Intrahepatic Bile Duct; 5.1 Hepatocellular Tumor-Like Lesions; 5.1.1 Focal Nodular Hyperplasia; 5.1.1.1 Pathogenesis and Mechanism; 5.1.1.2 Clinical Features; 5.1.1.3 Gross Features; 5.1.1.4 Microscopic Features; 5.1.1.5 Immunohistochemistry; 5.1.1.6 Differential Diagnosis; 5.1.1.7 Treatment and Prognosis.
520	3		_aThis book focuses on the pathological diagnosis of primary hepatic and bile duct tumors, and introduces the "Three Types and Six Sub-types" classification of hepatobiliary tumors. With more than 600 figures, including photographs and microscopy images, it highlights morphology, immunology and molecular pathology and their correlations with hepatic surgery and hepatic oncology. The book reviews the pathobiological characteristics of hepatic tumors and reveals the latest developments in this field. It is a valuable reference resource for hepatologists, pathologists and researchers.
650		7	_aVías biliares _xCáncer _2embne _0(OCoLC)fst00831715 _0 _9677694
700	1		_aCong, Wen-Ming.
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-981-10-3536-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988			_aSpringer_Medicine_2017
998			_b02/2018 _dz _e- _zSI
999			_c96106 _d96106 _x1